PRP is everywhere: facials, joint pain, even “P-shots.” But can it actually slow #aging? We break down the evidence in our latest post reviewing #longevity protocols. In short: #PRP helps some conditions, but don’t call it anti-aging just yet. Read more: linkedin.com/feed/update/ur…

Subscribe to our free newsletter and stay updated on our Hype vs. Reality series, active research projects, industry news, and other evidence-based educational resources ⬇️

From nutrients to lifestyle interventions, research is revealing strategies that can help protect #brain health as we age. We break down the #science in our latest post ⬇️ linkedin.com/feed/update/ur… #longevity #cognitive #aging

Is gene therapy the future of #longevity or just hype?From telomerase to epigenetic reprogramming, animal data is promising. But in humans, safety, ethics, and efficacy remain open questions. We break down the science here ⬇️ linkedin.com/feed/update/ur…

What should we cover next in our Hype vs. Reality series? Each Tuesday, our Hype vs. Reality publications dissect popular #longevity interventions, separating the hype from the #science. What would you most like to see next? Vote with the link below ⬇️ linkedin.com/feed/update/ur…

We talk a lot about #Alzheimers and dementia, but overlook a major risk to brain health: #depression. MDD accelerates biological brain aging and demands greater attention in the #longevity conversation. via Richard Siow Andrew D. Huberman, Ph.D. linkedin.com/feed/update/ur…

We’re proud to welcome Dr. Anna Erat to our Strategic Advisory Council (SAC). A physician-scientist and global thought leader in healthy #aging and #longevity, Dr. Erat brings deep clinical, academic, and strategic insight to our mission. Learn more: dr-erat.com

Hype vs. Reality: What does science really say about regenerative therapies and #aging? We've dove deep into stem cells, #exosomes, plasma therapies, PRP, and gene therapy. Some are promising, others still too early to call linkedin.com/feed/update/ur… #Longevity #Biotech

Last week, we explored how psychiatric disorders are a biological accelerator of brain #aging. But did you know that #menopause plays a key role in women’s higher risk of neurodegenerative & #neuropsychiatric disorders? linkedin.com/feed/update/ur… #longevity

Just wrapped up our Hype vs Reality series on cellular & regenerative therapies. Now, we dive into #longevity lifestyle interventions, starting with diets: plant-based, Mediterranean, and #keto. Learn more: linkedin.com/posts/longevit…

Hormone Replacement Therapy (HRT) offers relief for #menopause symptoms, but it's not without controversy. New data shows a more balanced risk profile, but experts still urge caution. If considering HRT, speak with a healthcare provider. linkedin.com/feed/update/ur… #longevity

Happy to be highlighted in a recent Forbes article, which explores why many longevity startups don’t succeed, and what’s truly working in the space. Proud to be recognized for our work in funding early-stage #longevity research More ⬇️ forbes.com/sites/sindhyav…

As part of our Hype vs Reality, we dive into a big question: high vs low #protein—what’s best? Evidence is divided, but here’s what we know: Moderate intake in midlife supports health. Higher intake in later life is key for muscle and independence. More: linkedin.com/feed/update/ur…

The Gates Foundation pledges $2.5B to women’s health, their biggest commitment yet. At the LSF, we’re also tackling female fertility & #longevity research to close the existing funding gap. Read more: linkedin.com/posts/longevit… #WomensHealth

Longevity isn’t just later decades; for women, seeds of long-term health are planted early. From adolescence to postmenopause, each stage has unique needs. Let’s make #WomensHealth a core #longevity strategy. Learn more: linkedin.com/feed/update/ur… #menopause #science #aging

We are proud to support ARDD Meeting, a global hub for #longevity science. As a Tier 5 Sponsor, we look forward to Aug 25–29 in Copenhagen! Alex Zhavoronkov, PhD (aka Aleksandrs Zavoronkovs) Dr. Evelyne Yehudit Bischof agingpharma.org

Intermittent #fasting (IF) and calorie restriction (CR) both target #longevity pathways like mTOR, autophagy, and insulin signaling. CR has stronger human evidence, but IF offers more flexibility. Both improve #healthspan if done safely. Read more: linkedin.com/feed/update/ur…

Excited to see colleagues at Lifespan Research Institute appoint @keithcomito as CEO & Oliver Medvedik as CSO! With a strengthened Scientific Advisory Board, LRI is set to push the frontier of #aging research & patient advocacy.

Every Thursday we spotlight women’s health topics that matter. Today: #CVD in women – risk rises after menopause, and symptoms often differ from men. Awareness and prevention saves lives. Learn more: linkedin.com/feed/update/ur… #longevity #menopause